{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/power-real-world-data-clinical-development-and-post-market-activities#webpage",
"url": "https://www.fortrea.com/insights/power-real-world-data-clinical-development-and-post-market-activities",
"name": "The power of real-world data in clinical development and post-market activities",
"description": "Explore this Fortrea white paper on the power of real-world data in clinical development and discover how real-world evidence (RWE) is transforming modern clinical research, evidence generation, and healthcare decision-making across the product development lifecycle. The white paper examines the growing importance of real-world data (RWD) in supporting clinical development strategies, observational research, patient outcomes analysis, and healthcare insights while demonstrating how integrated healthcare datasets and real-world patient information can provide a deeper understanding of treatment effectiveness, disease progression, clinical outcomes, and patient experiences outside traditional clinical trial settings. Learn how RWD and RWE approaches are helping organizations optimize clinical development programs, strengthen evidence generation strategies, improve patient-centered research initiatives, support more informed regulatory interactions, and enhance decision-making across complex healthcare and pharmaceutical development programs. The white paper also highlights how real-world evidence can complement traditional clinical trial data by supporting broader population insights, longitudinal patient analysis, and more effective evaluation of therapies in real-world care environments, enabling sponsors and healthcare stakeholders to improve development efficiency, generate meaningful clinical insights, and support better healthcare research and treatment strategies."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "The power of real-world data in clinical development and post-market activities",
"item": "https://www.fortrea.com/insights/power-real-world-data-clinical-development-and-post-market-activities"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/power-real-world-data-clinical-development-and-post-market-activities#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/power-real-world-data-clinical-development-and-post-market-activities#webpage"
},
"headline": "Real-World Data in Clinical Development & Evidence Generation Strategies | Fortrea White Paper",
"description": "Explore this Fortrea white paper on the power of real-world data in clinical development and discover how real-world evidence (RWE) is transforming modern clinical research, evidence generation, and healthcare decision-making across the product development lifecycle. The white paper examines the growing importance of real-world data (RWD) in supporting clinical development strategies, observational research, patient outcomes analysis, and healthcare insights while demonstrating how integrated healthcare datasets and real-world patient information can provide a deeper understanding of treatment effectiveness, disease progression, clinical outcomes, and patient experiences outside traditional clinical trial settings. Learn how RWD and RWE approaches are helping organizations optimize clinical development programs, strengthen evidence generation strategies, improve patient-centered research initiatives, support more informed regulatory interactions, and enhance decision-making across complex healthcare and pharmaceutical development programs. The white paper also highlights how real-world evidence can complement traditional clinical trial data by supporting broader population insights, longitudinal patient analysis, and more effective evaluation of therapies in real-world care environments, enabling sponsors and healthcare stakeholders to improve development efficiency, generate meaningful clinical insights, and support better healthcare research and treatment strategies.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-02/the-power-of-real-world-data-in-clinical-development.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-02-21",
"dateModified": "2025-02-21",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-02/the-power-of-real-world-data-in-clinical-development.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/power-real-world-data-clinical-development-and-post-market-activities#webpage",
"url": "https://www.fortrea.com/insights/power-real-world-data-clinical-development-and-post-market-activities",
"name": "The power of real-world data in clinical development and post-market activities",
"description": "Explore this Fortrea white paper on the power of real-world data in clinical development and discover how real-world evidence (RWE) is transforming modern clinical research, evidence generation, and healthcare decision-making across the product development lifecycle. The white paper examines the growing importance of real-world data (RWD) in supporting clinical development strategies, observational research, patient outcomes analysis, and healthcare insights while demonstrating how integrated healthcare datasets and real-world patient information can provide a deeper understanding of treatment effectiveness, disease progression, clinical outcomes, and patient experiences outside traditional clinical trial settings. Learn how RWD and RWE approaches are helping organizations optimize clinical development programs, strengthen evidence generation strategies, improve patient-centered research initiatives, support more informed regulatory interactions, and enhance decision-making across complex healthcare and pharmaceutical development programs. The white paper also highlights how real-world evidence can complement traditional clinical trial data by supporting broader population insights, longitudinal patient analysis, and more effective evaluation of therapies in real-world care environments, enabling sponsors and healthcare stakeholders to improve development efficiency, generate meaningful clinical insights, and support better healthcare research and treatment strategies."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "The power of real-world data in clinical development and post-market activities",
"item": "https://www.fortrea.com/insights/power-real-world-data-clinical-development-and-post-market-activities"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/power-real-world-data-clinical-development-and-post-market-activities#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/power-real-world-data-clinical-development-and-post-market-activities#webpage"
},
"headline": "Real-World Data in Clinical Development & Evidence Generation Strategies | Fortrea White Paper",
"description": "Explore this Fortrea white paper on the power of real-world data in clinical development and discover how real-world evidence (RWE) is transforming modern clinical research, evidence generation, and healthcare decision-making across the product development lifecycle. The white paper examines the growing importance of real-world data (RWD) in supporting clinical development strategies, observational research, patient outcomes analysis, and healthcare insights while demonstrating how integrated healthcare datasets and real-world patient information can provide a deeper understanding of treatment effectiveness, disease progression, clinical outcomes, and patient experiences outside traditional clinical trial settings. Learn how RWD and RWE approaches are helping organizations optimize clinical development programs, strengthen evidence generation strategies, improve patient-centered research initiatives, support more informed regulatory interactions, and enhance decision-making across complex healthcare and pharmaceutical development programs. The white paper also highlights how real-world evidence can complement traditional clinical trial data by supporting broader population insights, longitudinal patient analysis, and more effective evaluation of therapies in real-world care environments, enabling sponsors and healthcare stakeholders to improve development efficiency, generate meaningful clinical insights, and support better healthcare research and treatment strategies.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-02/the-power-of-real-world-data-in-clinical-development.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-02-21",
"dateModified": "2025-02-21",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-02/the-power-of-real-world-data-in-clinical-development.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
White Paper